Home
Lynx1 Capital Management, 10% Owner: TScan Therapeutics TCRX Buy · Filed 25/12/23
Trade details
- Type
- Insider buy
- Amount
- $67,950
- Shares · price
- 75,500 sh · $0.90 a share
- Held after
- 8,012,916 sh
- Trade date
- 25/12/22
- Filed
- 25/12/23
- Days to filing
- 1 days
First buy since 2023
- Insiders buying this week
- 2 insiders
- Holding change
- +1.0%
TScan Therapeutics trades, last 26 weeks
What else happened in TScan Therapeutics around then
Filed or reported within 30 days of the trade day · 25/11/22~01/21Lynx1 Capital Management's recent trades
- Lynx1 Capital Management
BuyPassage BIO
BuyPassage BIO
PASG
$206.2K
50,055 sh
$206.2K
Filed 06/29
Traded 06/25
- Lynx1 Capital Management
BuyKorro Bio
BuyKorro Bio
KRRO
$5,512
520 sh
$5,512
Filed 04/02
Traded 03/31
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$72.1K
80,069 sh
$72.1K
Filed 25/12/23
Traded 25/12/19
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$5,609
6,232 sh
$5,609
Filed 25/12/23
Traded 25/12/23
- Lynx1 Capital Management
BuyCullinan Therapeutics
BuyCullinan Therapeutics
CGEM
$1.4M
165,667 sh
$1.4M
Filed 25/10/30
Traded 25/10/28
